Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy. - Hu, Shuyi; Wu, Zipeng; Dai, Yingying; Shi, Xinhong; Hu, Qin; Liu, Caolu; Yifei Zhu; Ruofan Yu; Jingwen Li; Ying Liu; Tianyi Liu; Lin Lu; et al. (Cancer Biology & Medicine, 2025)